These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 33129109)
21. Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research. Tsukasaki K; Tobinai K Clin Cancer Res; 2014 Oct; 20(20):5217-25. PubMed ID: 25320371 [TBL] [Abstract][Full Text] [Related]
22. Biology and treatment of HTLV-1 associated T-cell lymphomas. Tsukasaki K; Tobinai K Best Pract Res Clin Haematol; 2013 Mar; 26(1):3-14. PubMed ID: 23768636 [TBL] [Abstract][Full Text] [Related]
23. [Progress in the management of ATL]. Ishitsuka K Rinsho Ketsueki; 2017; 58(6):676-682. PubMed ID: 28680001 [TBL] [Abstract][Full Text] [Related]
24. IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective γ-chain cytokines, decreases leukemic T-cell viability. Wang TT; Yang J; Zhang Y; Zhang M; Dubois S; Conlon KC; Tagaya Y; Hamele CE; Dighe S; Olson TL; Feith DJ; Azimi N; Waldmann TA; Loughran TP Leukemia; 2019 May; 33(5):1243-1255. PubMed ID: 30353031 [TBL] [Abstract][Full Text] [Related]
25. Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3 gene fusion. Kauffman EC; Lang M; Rais-Bahrami S; Gupta GN; Wei D; Yang Y; Sourbier C; Srinivasan R BMC Cancer; 2019 Sep; 19(1):917. PubMed ID: 31519159 [TBL] [Abstract][Full Text] [Related]
26. WRN-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells. Moles R; Bai XT; Chaib-Mezrag H; Nicot C J Hematol Oncol; 2016 Nov; 9(1):121. PubMed ID: 27829440 [TBL] [Abstract][Full Text] [Related]
27. [HSP90 inhibitor 17-AAG plays an important role in JAK3/STAT5 signaling pathways in HTLV-1 infection cell line HUT-102]. Yang QQ; Tan H; Fu ZP; Ma Q; Song JL Zhonghua Xue Ye Xue Za Zhi; 2017 Aug; 38(8):710-715. PubMed ID: 28954352 [No Abstract] [Full Text] [Related]
28. Effects of NVP-BEZ235, a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, on HTLV-1-infected T-cell lines. Ishikawa C; Senba M; Mori N Oncol Lett; 2018 Apr; 15(4):5311-5317. PubMed ID: 29552172 [TBL] [Abstract][Full Text] [Related]
29. Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells. Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Takasu N; Matsuda T; Ohta T; Tanaka Y; Ohshiro K; Mori N Int J Cancer; 2006 Feb; 118(3):765-72. PubMed ID: 16106398 [TBL] [Abstract][Full Text] [Related]
30. Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia Lymphoma. Tsukasaki K; Marçais A; Nasr R; Kato K; Fukuda T; Hermine O; Bazarbachi A Front Microbiol; 2020; 11():1207. PubMed ID: 32636814 [TBL] [Abstract][Full Text] [Related]
31. Clinical Trials and Treatment of ATL. Tsukasaki K; Tobinai K Leuk Res Treatment; 2012; 2012():101754. PubMed ID: 23259064 [TBL] [Abstract][Full Text] [Related]
32. HTLV-I Tax related dysfunction of cell cycle regulators and oncogenesis of adult T cell leukemia. Arima N; Tei C Leuk Lymphoma; 2001 Jan; 40(3-4):267-78. PubMed ID: 11426548 [TBL] [Abstract][Full Text] [Related]
33. Expression of functional interleukin-21 receptor on adult T-cell leukaemia cells. Ueda M; Imada K; Imura A; Koga H; Hishizawa M; Uchiyama T Br J Haematol; 2005 Jan; 128(2):169-76. PubMed ID: 15638850 [TBL] [Abstract][Full Text] [Related]
34. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia. Zhang Q; Lee B; Korecka M; Li G; Weyland C; Eck S; Gessain A; Arima N; Lessin SR; Shaw LM; Luger S; Kamoun M; Wasik MA Leuk Res; 1999 Apr; 23(4):373-84. PubMed ID: 10229324 [TBL] [Abstract][Full Text] [Related]
35. Atypical adult T-cell leukemia-lymphoma: diverse clinical manifestations of adult T-cell leukemia-lymphoma. Shimoyama M; Minato K; Tobinai K; Nagai M; Setoya T; Takenaka T; Ishihara K; Watanabe S; Hoshino H; Miwa M; Kinoshita M; Okabe S; Fukushima N; Inada N Jpn J Clin Oncol; 1983; 13 Suppl 2():165-87. PubMed ID: 6603526 [TBL] [Abstract][Full Text] [Related]
36. [Overview of ATL (adult T-cell leukemia) research]. Takatsuki K Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1763-71. PubMed ID: 2884929 [TBL] [Abstract][Full Text] [Related]
37. Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in Bartalucci N; Calabresi L; Balliu M; Martinelli S; Rossi MC; Villeval JL; Annunziato F; Guglielmelli P; Vannucchi AM Oncotarget; 2017 Nov; 8(57):96710-96724. PubMed ID: 29228564 [TBL] [Abstract][Full Text] [Related]
38. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. Bazarbachi A; Plumelle Y; Carlos Ramos J; Tortevoye P; Otrock Z; Taylor G; Gessain A; Harrington W; Panelatti G; Hermine O J Clin Oncol; 2010 Sep; 28(27):4177-83. PubMed ID: 20585095 [TBL] [Abstract][Full Text] [Related]
39. High expression of NAMPT in adult T-cell leukemia/lymphoma and anti-tumor activity of a NAMPT inhibitor. Kozako T; Aikawa A; Ohsugi T; Uchida YI; Kato N; Sato K; Ishitsuka K; Yoshimitsu M; Honda SI Eur J Pharmacol; 2019 Dec; 865():172738. PubMed ID: 31614144 [TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity of interleukin 2-toxin toward lymphocytes from patients with adult T-cell leukemia. Kiyokawa T; Shirono K; Hattori T; Nishimura H; Yamaguchi K; Nichols JC; Strom TB; Murphy JR; Takatsuki K Cancer Res; 1989 Jul; 49(14):4042-6. PubMed ID: 2786749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]